NCI | Technology Transfer

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

South Korea
2021-7026169
Filed on 2021-08-18

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Japan
2021-542206
Filed on 2021-07-20

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

European Patent
20705599.7
Filed on 2021-08-13

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

China
202080010373.0
Filed on 2021-07-22

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Canada
3127096
Filed on 2021-07-16

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION

Australia
2020211922
Filed on 2021-07-22

PREFERENTIAL GENERATION OF iPSC CARRYING ANTIGEN SPECIFIC TCRs FROM TUMOR INFILTRATING LYMPHOCYTES

Read more about PREFERENTIAL GENERATION OF iPSC CARRYING ANTIGEN SPECIFIC TCRs FROM TUMOR INFILTRATING LYMPHOCYTES

Patent Cooperation Treaty
PCT/US2021/046969
Filed on 2021-08-20

IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-1 (GPC1) FOR TREATING SOLID TUMORS

Read more about IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-1 (GPC1) FOR TREATING SOLID TUMORS

Patent Cooperation Treaty
PCT/US2021/045305
Filed on 2021-08-10

LZK-TARGETING DEGRADERS AND METHODS OF USE

Read more about LZK-TARGETING DEGRADERS AND METHODS OF USE

Patent Cooperation Treaty
PCT/US2021/048600
Filed on 2021-09-01

METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY

Read more about METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY

European Patent
20306327.6
Filed on 2020-11-05

Subscribe to NCI